VANCOUVER, BC--(Marketwired - October 11, 2016) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Winks Convenience stores.
Winks is an affiliate retail banner program developed by Mac's Convenience Stores Inc. for independent convenience stores in Western Canada. Since its beginning in 2003, there are now over 600 Winks members in Western Canada and 150 in Ontario. Winks was developed to assist independent operators that are motivated to grow their business. Winks is a comprehensive program that balances the needs of the independent operator, the suppliers and the distributors.
Alimentation Couche-Tard, the largest convenience store operator in Canada operates the Winks program with such additional operating banners as Couche-Tard and Mac's here in Canada, the American market is predominately run under the trademark of Circle K. The average store size is 3,000 square feet. There is a network of 5,906 convenience stores, 4,122 of which include gas pumps located in 11 large geographic markets across North America. More than 52,000 people are employed through the Alimentation Couche-Tard retail convenience network and service centers.
NeutriSci President Mr. Glen Rehman stated, "Neuenergy has steadily gained retail traction and consumer demand over the past 12 months. This most recent distribution agreement further expands locations across Canada where neuenergy can be purchased. Neuenergy is now available in convenience stores, grocery and specialty retailers across Canada. These diverse channels provide consumers local choices when purchasing neuenergy, thus driving sales and increased revenue."
Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.
To find out more about neuenergy®, please visit www.getneuenergy.com.
On Behalf of the Board of Directors of NEUTRISCI INTERNATIONAL INC.
NeutriSci International Inc.
About NeutriSci International Inc.
NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focussed on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company's natural energy and focus supplement that has at its core, the beneficial effects of blueberries.
Neuenergy® contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine, and is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. To find out more about neuenergy®, please visit www.getneuenergy.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.